Monheim, Germany, July 6, 2010 (ots/PRNewswire) - The findings of a landmark Canine Vector Borne Disease (CVBD) prevention field study, published in Veterinary Parasitology today, showed the remarkable repelling efficacy of Advantix(R) in protecting dogs from ticks and sand flies and thereby reducing the risk of ...
Toronto, July 2, 2010 (ots/PRNewswire) - Biosign Technologies Inc. (CNSX: BIO) today announced the signing of an exclusive Master Distribution Agreement with Swiss-based DynamiCARE AG to distribute the Biosign products in Switzerland, Germany, France, and Austria, with an option to expand distribution throughout Europe. Under the terms of the agreement, DynamiCARE will pay an initial fee of CDN $2.5 million, with a ...
Castres, France, July 2, 2010 (ots/PRNewswire) - Olivier Bohuon will be replacing Jean-Pierre Garnier as Chief Executive Officer at Pierre Fabre Group starting September 1, 2010. Until now, Olivier Bohuon, 51, was Executive Vice-President of the Abbott Corporation and President of its pharmaceutical division. As such, he ran the group's entire pharmaceutical activities from Chicago ($22 billion in sales). In 2003, he was named the group's President for European ...
Copenhagen, June 30, 2010 (ots/PRNewswire) - The world's most-travelled hot dog stand is in South Africa during the FIFA World Cup 2010 to spread Danish culture and values and to raise money for education of South African bushmen children. The Danish hot dog stand, Hottie, has travelled around the world since 2003. Hottie generates its own electricity with pedal power and through the solar panels on the roof. More ...
Wokingham, England, June 28, 2010 (ots/PRNewswire) - Following an enthusiastic expansion programme into new markets, Kowa Company, Ltd. (President: Yoshihiro Miwa), headquartered in Nagoya, Japan, has granted Abbott, headquartered in Illinois, USA the exclusive license to distribute and market pitavastatin ...
Munich, June 28, 2010 (ots/PRNewswire) - Interim data from a prospective Investigator Initiated Trial (IIT) presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA(R) (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated ...
Bristol-Myers Squibb and AstraZeneca
Orlando, Florida, June 26, 2010 (ots/PRNewswire) - Results from a 24-week Phase 3 clinical study demonstrated that the addition of the investigational drug dapagliflozin achieved reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c), in inadequately controlled type 2 diabetes patients who were ...
Bristol-Myers Squibb and AstraZeneca
Orlando, Florida, June 26, 2010 (ots/PRNewswire) - Bristol-Myers Squibb Company and AstraZeneca today announced results from a 52-week Phase 3b study in adults with type 2 diabetes who had inadequate glycemic control on metformin therapy plus diet and exercise. This study found that the addition of ...
Bristol-Myers Squibb and AstraZeneca
Orlando, Florida, June 26, 2010 (ots/PRNewswire) - Bristol-Myers Squibb Company and AstraZeneca today announced results up to 76-weeks from a Phase 3 study of ONGLYZA(TM) (saxagliptin) as initial combination therapy with metformin, which produced long-term glycemic improvement [as measured by glycosylated ...
Ottawa, June 24, 2010 (ots/PRNewswire) - MDS Nordion, a leading provider of products and services to the global health science market, Guerbet, a pharmaceutical group specialized in medical imaging, and Cyceron, a biomedical imaging centre in France, announced today they have entered into an agreement to develop new Positron Emission Tomography (PET) radiotracers ...
Brussels, June 23, 2010 (ots/PRNewswire) - TechTeam Global, Inc. , a worldwide provider of information technology outsourcing and business process outsourcing services, announced today that it has won a three-year contract to provide service desk support to Europcar, the European leader in passenger car and light utility vehicle rentals. Under the agreement, ...
Hamburg and Calgary, Canada, June 22, 2010 (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix" or the "Company") announced today that key scientific data was communicated in an oral presentation highlighting the novel features of the Company's lead drug RVX-208 at the European Atherosclerosis Society Congress (EAS) conference being held in Hamburg, Germany. The presentation titled "RVX-208 given orally raises ...
Waterford, Ireland, June 22, 2010 (ots/PRNewswire) - A new beginning for Waterford Crystal is marked today with the official opening of the House of Waterford Crystal on the Mall in the heart of Waterford City. The new facility, which comprises manufacturing facility, visitor centre and retail outlet, ensures ...
Oslo, June 21, 2010 (ots/PRNewswire) - Data announced for the first time at ESH suggest that patients with hypertension are at increased cardiovascular risk due to clinician inertia, because physicians are failing to treat targets set by accepted ESH-ESC (European Society of Hypertension and European Society of Cardiology) guidelines for the management of arterial hypertension and do not act soon enough to reduce blood ...
Antony, France, June 21, 2010 (ots/PRNewswire) - Stallergenes S.A. announces the results of a phase III clinical trial (VO55.06) conducted in China aimed at assessing the efficacy and safety of sublingual immunotherapy (Staloral(R) mites 300) in adult patients suffering from asthma triggered by house dust mites. Study VO55.06 is a phase III randomized, ...
Porton Down, England, June 21, 2010 (ots/PRNewswire) - GW Pharmaceuticals plc (GWP:AIM) today announces the UK launch of Sativex(R), its Oromucosal Spray for the treatment of spasticity due to Multiple Sclerosis (MS). Sativex(R) is the world's first prescription cannabis medicine and the UK is the first country in the world to grant a full regulatory authorization ...
Rome, June 19, 2010 (ots/PRNewswire) - /OFF HOLD OFF HOLD OFF HOLD - Servier, PIV395527 The following release: "Protelos(R) (Strontium Ranelate) Builds Stronger Bone Compared to Bisphosphonates" is now OFF HOLD. Distribution time: 19 Jun 2010 08:15 GMT The osteoporosis treatment Protelos(R) (strontium ranelate, Servier) has greater effects than the commonly prescribed bisphosphonate alendronate on bone ...
Basel, Switzerland, June 18, 2010 (ots/PRNewswire) - Roche (SIX: RO, ROG; OTCQX: RHHBY) (http://www.roche.com/investors.htm) today announced that new data being presented at the European League Against Rheumatism (EULAR) congress demonstrates that RoACTEMRA (known as ACTEMRA outside Europe) is highly effective in improving the signs and symptoms of systemic Juvenile ...
Nice, France, June 17, 2010 (ots/PRNewswire) - Medtronic, Inc. today announced European launch of the Protecta(TM) portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds). The implantable defibrillators feature Medtronic-exclusive SmartShock(TM) ...
St. Petersburg, Russia, June 16, 2010 (ots/PRNewswire) - In 2010, at the St. Petersburg International Economic Forum, leading government officials, business and financial figures, experts and media heads from Russia and across the globe gather to identify and take action on measures to secure the recovery of the global economy while discussing new ideas and solutions to forge more sustainable growth. To view the ...
The European Tech Tour Association (ETT)
Helsinki, Tallinn, Estonia and Stockholm, June 15, 2010 (ots/PRNewswire) -- The European Tech Tour today announced the 30 selected companies of the Nordic Tech Tour 2010. The finalists represent the region's most promising, high-growth, early- and expansion-stage technology companies. The 30 companies - all ...
Arnhem, The Netherlands, June 15, 2010 (ots/PRNewswire) - Teijin Aramid will restart the last spinning line for aramid fibers at its Emmen, The Netherlands plant. Demand for Teijin Aramid's super-strong Twaron fiber declined sharply in 2009 during the economic crisis. The forecast for production of aramid in 2010 has been adjusted upwards. With the restart of the last spinning line, all spinning lines will be operational and production will be at full capacity. The ...
Quebec, Canada, June 14, 2010 (ots/PRNewswire) - Obzerv Technologies Inc. today announces the commercial availability of a Modular Active Range-Gated Camera. Airborne Multi-Spectral Imaging Turrets manufacturers around the world are constantly increasing the number of sensors available as well as their ...
Copenhagen, June 12, 2010 (ots/PRNewswire) - 30,000 People run Across the Øresund Bridge Between Denmark and Sweden When the Bridge Run 2010 Kicks off Saturday, June 12. Runners of all Ages From More Than 25 Countries Participate in the Half Marathon Over and Under the sea, an Event That Also Marks the Start of the Celebrations for the Øresund Bridge's Tenth Anniversary. In 1999, 2,000 commuters crossed the ...
Zug, Switzerland, June 11, 2010 (ots/PRNewswire) - Amgen (Europe) today launched ITPvillage.com, a dedicated website bringing together patients, healthcare professionals and those who care for people affected by ITP, at the 15th Congress of European Hematology Congress in Barcelona, Spain. For many patients living with ITP, it can be an extremely isolating and ...
International Gay & Lesbian Chamber of Commerce
Amsterdam, June 10, 2010 (ots/PRNewswire) - To view this Social Media Release, please enter the following address in your web browser: http://smr.newswire.ca/en/the-international-gay-lesbian-chamber-of-co mmerce/iglcc-announces-the-most-gay-friendly-corporations (Due to the length of these URLs, it may be ...
Paris, June 9, 2010 (ots/PRNewswire) - Valeo announces that its second generation Stop-Start system will be launched by PSA Peugeot Citroen in the third quarter of 2010. The system, coupled with the HDi diesel engines of the Peugeot and Citroen brands, will be featured on both manual and automated manual transmission models and will equip a million vehicles by ...
Lugano, Switzerland/Woodcliff Lake, NJ, USA (ots) - Helsinn Healthcare S.A. and Eisai Inc. today announce the signing of a licensing agreement granting Eisai Inc. commercialization rights for a new product for potential use in the prevention of chemotherapy-induced nausea and vomiting (CINV) in the United ...
Chicago, June 8, 2010 (ots/PRNewswire) - New data show that first-line treatment with Tarceva(R)(erlotinib) delivered exceptional survival benefits in patients with advanced lung adenocarcinoma (a form of non small cell lung cancer) with epidermal growth factor receptor (EGFR) activating mutations.[1] The phase II data show that Tarceva plus chemotherapy resulted in ...